PCR Market for Life Sciences and Diagnostics (qPCR & dPCR, TMA and Other NAAT)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,995	427 Pages	Kalorama Information	April, 2017	KLI15318010

Attention: There is an updated edition available for this report.

Best Price Guarantee
Price	from $3,995
Length	427 Pages
Publisher	Kalorama Information
Published Date	April, 2017
SKU	KLI15318010

PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT)

Polymerase chain reaction (PCR) technology is used in life science (research) activities and also in clinical medicine. PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) includes opportunity estimates for both research and diagnostic uses of PCR, by geography, with forecasts to 2021; global analysis of PCR and other NAAT technologies; examination of the applications of PCR and other NAAT in research and clinical diagnostics; tables listing agreements made by PCR and other NAAT companies, including investments and financing agreements, acquisitions, collaborations, and other agreements; and examination of market forces, issues, and trends in the nucleic acid amplification market. Abbott Laboratories, Agilent Technologies, Hologic, Qiagen, Roche, and Thermo Fisher Scientific are among the companies active in PCR and other NAAT products and applications that are profiled in the report.

Executive Summary
- Nucleic Acid Amplification Testing Overview
- Scope and Methodology
- Market Overview
  - Table PCR and Other NAAT Market, Worldwide, 2016 and 2021 [All NAATs - Life Science and Clinical Markets] (in millions USD)
- Future Prospects in the PCR Market
Introduction
- Development and Evolution of Polymerase Chain Reaction and Other Nucleic Acid Amplification Tests
  - Development and Evolution of PCR
  - Other Nucleic Acid Amplification Test Methods
  - Advances in Nucleic Acid Amplification Technology and Emerging Applications
- Point-of-View
Technology Trends and Innovation
- Polymerase Chain Reaction (PCR) - Overview
  - PCR, RT-PCR, and qPCR
  - Digital PCR
    - Table Selected Companies with Digital PCR Technology (For Research and/or Diagnostic Tests)
  - Multiplex PCR
    - Table Selected Companies with Multiplex PCR Technology [Note: This is not a comprehensive list of all companies with multiplex PCR technology/tests.]
  - Other Modifications of PCR
    - Table Selected Companies with Innovative PCR-Based Methods
- Other Nucleic Acid Amplification Test (NAAT) Methods
  - Isothermal NAAT Methods in Clinical Laboratories
  - Rapid Isothermal NAAT Methods in Decentralized Settings - Near Patient and Point-of-Care
    - Table Companies with Other Nucleic Acid Amplification Test Methods
- Platforms Used in Different NAAT Markets - Research, Clinical Laboratories, and Point-of-Care Testing
  - Table Selected Companies Marketing PCR Instruments/Reagents to the Life Sciences Market
  - Table Selected Companies Marketing NAAT Platforms/Tests to Clinical Laboratories
  - Table Selected Companies with NAAT Platforms and Tests for Decentralized Testing or Point-of-Care Settings
- New Applications of PCR - Combining PCR with Other Technologies
  - PCR as Part of Sample Prep before DNA Sequencing
    - Table Examples of Companies Using PCR during Sample Prep before DNA Sequencing
  - PCR before Mass Spectrometry
    - Table Selected Companies Developing Platforms That Use PCR before Analysis by Mass Spectrometry
  - Other Technologies Being Used with PCR
    - Table Selected Companies Using PCR with Other Technologies (Beyond Sequencing and Mass Spectrometry)
Nucleic Acid Amplification Tests in Research and the Clinical Laboratory
- Research Applications of Polymerase Chain Reaction
- Infectious Disease Diagnostics
  - Infectious Disease Diagnostic Tests
    - Table Selected Common Microorganisms Detected by Clinical NAAT Tests
    - Table Selected Companies Marketing PCR/NAAT Infectious Disease Tests (Single or Limited Number of Analytes)
    - Table Selected Companies Marketing PCR/NAAT Syndromic Tests/Panels for Infectious Diseases
  - Antibiotic Resistance/Susceptibility Testing
    - Table Selected Companies Marketing PCR/NAAT-Based Antibiotic Resistance/Susceptibility Tests
  - Rapid Near-Patient or Point-of-Care Testing for Infectious Diseases
    - Table Selected Companies Marketing Rapid Near-Patient/Point-of-Care PCR/NAAT Infectious Disease Tests
    - Table CLIA Waived NAAT Infectious Disease Tests
- Oncology
  - Cancer Risk
  - Cancer Screening
    - Table Selected Companies Developing/Marketing Diagnostic Tests for HPV
    - Table Selected Companies Developing/Marketing PCR/NAAT Tests for Cancer Screening (Not including HPV Tests for Cervical Cancer)
  - Cancer Diagnostics (Diagnosis, Prognosis, Monitoring, Response to Therapy)
    - Table Selected Companies Developing/Marketing PCR/NAAT Tests for Diagnosis/Prognosis/Predicting Response to Cancer Therapy
    - Table Selected PCR/NAAT Based, FDA Cleared/Approved Companion Diagnostic Tests
- Cardiovascular Disease
  - Table Selected Companies Developing/Marketing PCR Tests for Risk of Thrombophilia
  - Table Selected Companies Developing/Marketing PCR Warfarin Sensitivity Tests
  - Table Selected Companies Developing/Marketing Other PCR-Based Cardiovascular Tests
- Genetic Testing
  - Inherited (Genetic) Disorders
    - Table Selected Companies Developing/Marketing PCR Tests for Risk of Inherited (Genetic) Disorders
  - Drug Metabolism - Pharmacogenomics Testing
    - Table Pharmacogenomic Biomarkers in Drug Labeling
    - Table Selected Companies Developing/Marketing PCR Tests for Pharmacogenomics (Drug Metabolism)
  - HLA Typing
    - Table Selected Companies Developing/Marketing PCR Tests for HLA Typing
- Other Clinical Applications of Polymerase Chain Reaction
  - Table Selected Companies Developing/Marketing PCR Tests for Other Clinical Applications
- Transfusion Medicine - Blood Screening
  - Table Selected Companies Developing/Marketing PCR Tests Transfusion Medicine
- Non-Clinical Applications of Polymerase Chain Reaction
Deals - Polymerase Chain Reaction/Nucleic Acid Amplification Test Companies
- Investments and Financing Agreements
  - Table Selected Investment and Financing Agreements in NAAT Companies
- Mergers and Acquisitions
  - Table Selected Acquisitions of NAAT Companies
- Corporate Agreements and Collaborations (Not Including Pharmaceutical Companies)
  - Table Selected Agreements between NAAT Companies and Other Companies [Not Including Pharmaceutical Companies]
- Collaborations/Agreements with Pharmaceutical and Biopharmaceutical Companies
  - Table Selected Agreements between NAAT Companies and Pharmaceutical or Biopharmaceutical Companies
- Collaborations and Other Agreements with Universities, Non-Profit Research Institutes and Government
  - Table Selected NAAT Company Agreements with Academic or Other Non-Profit Organizations
Market Drivers and Challenges - Nucleic Acid Amplification Test Market
- Issues and Hurdles Faced by PCR Companies Selling to the Life Science (Research) Market
- Clinical Market Drivers
- Point-of-Care Testing Market Drivers and Challenges/Hurdles
- Competition from Companies Utilizing PCR and Other NAAT Technologies
- Competition and Market Opportunities Driven by Other (non-NAAT) Technologies
  - Competition
  - Opportunities
- Regulation of In Vitro Diagnostics
- Laboratory Developed Tests
- Reimbursement
- Future Prospects
  - Table Trends in the Polymerase Chain Reaction/Nucleic Acid Amplification Test Market
Polymerase Chain Reaction (PCR) and Nucleic Acid Amplification Test (NAAT) Market Analysis
- Nucleic Acid Amplification Test Market Overview
  - Table Nucleic Acid Amplification Test Market, Worldwide, 2016 and 2021 [All NAATs -Life Science and Clinical Markets] (in millions USD)
- Life Science NAAT Market
  - Past and Future Growth of Overall Life Science PCR Market
    - Table Growth of the Life Science PCR Market (1990 - 2016) [# Abstracts Found per Year in PubMed search for "'polymerase chain reaction' or pcr"] (Accessed March 27, 2017)
  - Life Science PCR Market - Instruments versus Consumables
    - Table Life Science PCR Market, Instruments versus Consumables, Worldwide, 2016 and 2021 (in millions USD)
  - Life Science PCR Market - By Geographical Distribution
    - Table Life Science PCR Market, by Geographical Distribution
  - Life Science PCR Market by Type of PCR
    - Table Life Science PCR Market, by Type of PCR, Worldwide, 2016
    - Table Life Science PCR Market, by Type of PCR, Worldwide, 2021
- Clinical NAAT Market - Global Market
  - Table Clinical PCR and Other NAAT Market by Disease Indication, Worldwide, 2016 and 2021 (in millions USD)
  - Table Clinical PCR and Other NAAT Market by Geographical Region, Worldwide, 2016 and 2021 (in millions USD)
  - Table Clinical PCR and Other NAAT Market, by Type of NAAT, Worldwide, 2016
  - Table Clinical PCR and Other NAAT Market, by Type of NAAT, Worldwide, 2021
- Clinical (Diagnostic) NAAT Market - Infectious Disease
  - Table Diagnostic Infectious Disease PCR and Other NAAT Market by Type of Infection, Worldwide, 2016 and 2021 (in millions USD)
  - Table Diagnostic Infectious Disease PCR and Other NAAT Market, Worldwide by Geographical Region, 2016 and 2021 (in millions USD)
- Clinical (Diagnostic) NAAT Market - Oncology
  - Emerging Market for NAAT-Based Cancer Screening
  - Cancer Diagnosis/Prognosis/Personalized Medicine/Monitoring Market
    - Table Diagnostic Oncology PCR and Other NAAT Market (Screening, Diagnosis/Prognosis/Personalized Medicine/Monitoring) Worldwide, 2016 and 2021 (in millions USD)
    - Table Diagnostic Oncology PCR and Other NAAT Market by Geographical Distribution, Worldwide, 2016 and 2021 (in millions USD)
- Clinical (Diagnostic) NAAT Market - Genetic Testing
  - Table Diagnostic PCR and Other NAAT Genetic Testing Market by Market Segment (Thrombophilia, Inherited Diseases, Pharmacogenomics) Worldwide, 2016 and 2021(in millions USD)
  - Table Diagnostic Inherited Disease PCR and Other NAAT Market by Geographical Distribution, Worldwide, 2016 and 2021 (in millions USD)
- Clinical (Diagnostic) NAAT Market - Transplantation Diagnostics
  - Table Diagnostic Transplantation Diagnostics PCR and Other NAAT Market by Geographical Distribution, Worldwide, 2016 and 2021 (in millions USD)
- NAAT Blood Screening Market
  - Table PCR and Other NAAT Blood Screening Market, by Geographical Distribution, Worldwide, 2016 and 2021 (in millions USD)
Company Profiles
- Abbott Laboratories
  - Recent Revenue History
    - Table Abbott Revenues (2013 to 2016)
  - Company Overview - With a Focus on Polymerase Chain Reaction
- Agena Bioscience, Inc.
- Agilent Technologies Inc.
  - Recent Revenue History
    - Table Agilent Technologies Revenues (2014, 2015, 2016)
  - Company Overview
- Alere Inc.
  - Recent Revenue History
    - Table Alere Inc. Revenues (2014, 2015, and first three quarters of 2016)
  - Company Overview
- Amoy Diagnostics Co., Ltd.
- Asuragen, Inc.
- Atlas Genetics Ltd
- AutoGenomics, Inc.
- Beckman Coulter, Inc. (A Danaher Corporation Company)
  - Revenue History
  - Company Overview
- Becton, Dickinson and Company (BD)
  - Recent Revenue History
    - Table Becton Dickinson Revenues (2014 to 2016)
  - Company Overview
- Biocartis Group NV
  - Recent Revenue History
    - Table Biocartis Revenues (2014 to 2016)
  - Company Overview
- BioFire Diagnostics, LLC. (Acquired by bioMérieux)
  - Recent Revenue History and Other Financial Information
  - Company Overview
- bioMérieux SA
  - Recent Revenue History
    - Table bioMérieux Revenues (2013 to 2016)
    - Table bioMérieux Revenues (2013, 2014, 2015, 3 quarters of 2016)
  - Company Overview
- Bio-Rad Laboratories, Inc.
  - Recent Revenue History
    - Table Bio-Rad Laboratories Net Sales (2014 to 2016)
  - Company Overview
- Bruker Corporation
  - Recent Revenue History
    - Table Bruker Corporation Revenues (2013 - 2016)
  - Company Overview
- Canon BioMedical
- Cepheid (A Danaher Company)
  - Recent Revenue History
    - Table Cepheid Revenues (2013 - 2015)
  - Company Overview
- Curetis
  - Recent Revenue History
    - Table Curetis Revenues (2014, 2015, and first three quarters of 2016)
  - Company Overview
- DiaSorin S.p.A.
  - Recent Revenue History
    - Table DiaSorin Revenues (2015 and 2016)
  - Company Overview
- Eiken Chemical Co., Ltd.
  - Recent Revenue History
    - Table Eiken Chemical Co., Ltd. Revenues (FY2014 - FT 2016)
  - Company Overview
- ELITechGroup
- GenePOC Inc.
- GenMark Diagnostics, Inc.
  - Recent Revenue History
    - Table GenMark Diagnostics Revenue (2013-2016)
  - Company Overview
- Genomic Health, Inc.
  - Recent Revenue History
    - Table Genomic Health Revenues (2014 to 2016)
  - Company Overview
- Grifols
  - Recent Revenue History
    - Table Grifols Revenues (2015 and 2016)
  - Company Overview
- Hologic, Inc.
  - Recent Revenue History
    - Table Hologic Revenues (FY2014 - FY 2016)
  - Company Overview
- Invivoscribe Technologies, Inc.
- Janssen Diagnostics (Division of Janssen Pharmaceutica NV)
- Luminex Corporation
  - Recent Revenue History
    - Table Luminex Corporation Revenues (2014 - 2016)
  - Company Overview
- Mast Group
- Meridian Bioscience, Inc.
  - Recent Revenue History
    - Table Meridian Bioscience, Inc. Revenues (FY2014 - FT 2016)
  - Company Overview
- Multiplicom NV (Part of Agilent Technologies)
- QIAGEN N.V.
  - Recent Revenue History
    - Table QIAGEN Revenues (2014, 2015, 2016)
  - Company Overview
- QuanDx Inc.
- QuantuMDx Group
- Quidel, Inc.
  - Recent Revenue History
    - Table Quidel Revenues (2014 - 2016)
  - Company Overview
- Qvella Corporation
- RainDance Technologies, Inc. (Acquired by Bio-Rad Laboratories)
- Roche
  - Recent Revenue History
    - Table Roche Revenues (2015 - 2016) (mCHF)
    - Table Roche Revenues (2015 - 2016) (mUSD)
  - Company Overview
- Siemens Healthineers
  - Recent Revenue History
    - Table Siemens Revenues (2015 - 2016) (in millions of euros)
  - Company Overview
- Spartan Bioscience Inc.
- STAT-Diagnostica
- T2 Biosystems, Inc.
  - Recent Revenue History
    - Table T2 Biosystems, Inc. Revenues (2014-2016)
  - Company Overview
- Thermo Fisher Scientific, Inc.
  - Recent Revenue History
    - Table Thermo Fisher Scientific Revenues (2014-2016)
  - Company Overview